{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:43:09Z","timestamp":1784310189441,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"DOI":"10.7759\/cureus.98265","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T22:00:04Z","timestamp":1764626404000},"source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of Probiotic Supplementation in the Management of Psoriasis: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Muhammad","family":"Waqas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inzamam","family":"Sarwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare13192437","article-title":"Global psoriasis burden 1990-2021: evolving patterns and socio-demographic correlates in the Global Burden of Disease 2021 update","volume":"13","author":"Li D","year":"2025","unstructured":"Li D, Fan S, Song J, Zhao H, Guo L, Li P, Xu X. Global psoriasis burden 1990-2021: evolving patterns and socio-demographic correlates in the Global Burden of Disease 2021 update. Healthcare (Basel). 2025, 13:2437. 10.3390\/healthcare13192437","journal-title":"Healthcare (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.743180","article-title":"The global, regional, and national burden of psoriasis: results and insights from the Global Burden of Disease 2019 study","volume":"8","author":"Damiani G","year":"2021","unstructured":"Damiani G, Bragazzi NL, Karimkhani Aksut C, et al.. The global, regional, and national burden of psoriasis: results and insights from the Global Burden of Disease 2019 study. Front Med (Lausanne). 2021, 8:743180. 10.3389\/fmed.2021.743180","journal-title":"Front Med (Lausanne)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1448626","article-title":"The efficacy and safety of probiotics in the adjuvant treatment of psoriasis: a systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Zhu Y","year":"2024","unstructured":"Zhu Y, Xu F, Chen H, Zheng Q. The efficacy and safety of probiotics in the adjuvant treatment of psoriasis: a systematic review and meta-analysis of randomized controlled trials. Front Med (Lausanne). 2024, 11:1448626. 10.3389\/fmed.2024.1448626","journal-title":"Front Med (Lausanne)"},{"key":"ref4","article-title":"Interaction between intestinal flora and psoriasis: research progress","volume":"36","author":"Zhu Z","year":"2024","unstructured":"Zhu Z, Ma S, Zhang K. Interaction between intestinal flora and psoriasis: research progress. Chin J Microecol. 2024, 36:843-54.","journal-title":"Chin J Microecol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.16299","article-title":"Efficacy of probiotic supplementation in the treatment of psoriasis-a systematic review and meta-analysis","volume":"23","author":"Wei K","year":"2024","unstructured":"Wei K, Liao X, Yang T, et al.. Efficacy of probiotic supplementation in the treatment of psoriasis-a systematic review and meta-analysis. J Cosmet Dermatol. 2024, 23:2361-7. 10.1111\/jocd.16299","journal-title":"J Cosmet Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03303-4","article-title":"Efficacy and safety of gut microbiota-based therapies in autoimmune and rheumatic diseases: a systematic review and meta-analysis of 80 randomized controlled trials","volume":"22","author":"Zeng L","year":"2024","unstructured":"Zeng L, Yang K, He Q, et al.. Efficacy and safety of gut microbiota-based therapies in autoimmune and rheumatic diseases: a systematic review and meta-analysis of 80 randomized controlled trials. BMC Med. 2024, 22:110. 10.1186\/s12916-024-03303-4","journal-title":"BMC Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1344963","article-title":"IL-17A inhibitors alleviate psoriasis with concomitant restoration of intestinal\/skin microbiota homeostasis and altered microbiota function","volume":"15","author":"Zhao H","year":"2024","unstructured":"Zhao H, Shang L, Zhang Y, et al.. IL-17A inhibitors alleviate psoriasis with concomitant restoration of intestinal\/skin microbiota homeostasis and altered microbiota function. Front Immunol. 2024, 15:1344963. 10.3389\/fimmu.2024.1344963","journal-title":"Front Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/cells9092044","article-title":"Decoding IL-23 signaling cascade for new therapeutic opportunities","volume":"9","author":"Pastor-Fern\u00e1ndez G","year":"2020","unstructured":"Pastor-Fern\u00e1ndez G, Mariblanca IR, Navarro MN. Decoding IL-23 signaling cascade for new therapeutic opportunities. Cells. 2020, 9:2044. 10.3390\/cells9092044","journal-title":"Cells"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/7552546","article-title":"The effectiveness and safety of probiotic supplements for psoriasis: a systematic review and meta-analysis of randomized controlled trials and preclinical trials","volume":"2021","author":"Zeng L","year":"2021","unstructured":"Zeng L, Yu G, Wu Y, Hao W, Chen H. The effectiveness and safety of probiotic supplements for psoriasis: a systematic review and meta-analysis of randomized controlled trials and preclinical trials. J Immunol Res. 2021, 2021:7552546. 10.1155\/2021\/7552546","journal-title":"J Immunol Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2021.08.021","article-title":"The skin microbiome and the gut-skin axis","volume":"39","author":"Sinha S","year":"2021","unstructured":"Sinha S, Lin G, Ferenczi K. The skin microbiome and the gut-skin axis. Clin Dermatol. 2021, 39:829-39. 10.1016\/j.clindermatol.2021.08.021","journal-title":"Clin Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14016","article-title":"Targeting the gut-skin axis-probiotics as new tools for skin disorder management?","volume":"28","author":"Sz\u00e1nt\u00f3 M","year":"2019","unstructured":"Sz\u00e1nt\u00f3 M, D\u00f3zsa A, Antal D, Szab\u00f3 K, Kem\u00e9ny L, Bai P. Targeting the gut-skin axis-probiotics as new tools for skin disorder management?. Exp Dermatol. 2019, 28:1210-8. 10.1111\/exd.14016","journal-title":"Exp Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10051037","article-title":"Gut-skin axis: unravelling the connection between the gut microbiome and psoriasis","volume":"10","author":"Thye AY","year":"2022","unstructured":"Thye AY, Bah YR, Law JW, et al.. Gut-skin axis: unravelling the connection between the gut microbiome and psoriasis. Biomedicines. 2022, 10:1037. 10.3390\/biomedicines10051037","journal-title":"Biomedicines"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60101619","article-title":"The contribution of the skin microbiome to psoriasis pathogenesis and its implications for therapeutic strategies","volume":"60","author":"Radaschin DS","year":"2024","unstructured":"Radaschin DS, Tatu A, Iancu AV, Beiu C, Popa LG. The contribution of the skin microbiome to psoriasis pathogenesis and its implications for therapeutic strategies. Medicina (Kaunas). 2024, 60:1619. 10.3390\/medicina60101619","journal-title":"Medicina (Kaunas)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1083432","article-title":"The role of short-chain fatty acids in inflammatory skin diseases","volume":"13","author":"Xiao X","year":"2022","unstructured":"Xiao X, Hu X, Yao J, et al.. The role of short-chain fatty acids in inflammatory skin diseases. Front Microbiol. 2022, 13:1083432. 10.3389\/fmicb.2022.1083432","journal-title":"Front Microbiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s13671-017-0178-5","article-title":"The role of the skin and gut microbiome in psoriatic disease","volume":"6","author":"Yan D","year":"2017","unstructured":"Yan D, Issa N, Afifi L, Jeon C, Chang HW, Liao W. The role of the skin and gut microbiome in psoriatic disease. Curr Dermatol Rep. 2017, 6:94-103. 10.1007\/s13671-017-0178-5","journal-title":"Curr Dermatol Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.18585\/inabj.v16i4.3155","article-title":"Lactiplantibacillus plantarum IS-10506 supplementation improves clinical outcome and immunology markers in psoriasis vulgaris patients: a randomized controlled trial","volume":"16","author":"Umborowati MA","year":"2024","unstructured":"Umborowati MA, Hasna IH, Endaryanto A, Surono IS, Prakoeswa CR. Lactiplantibacillus plantarum IS-10506 supplementation improves clinical outcome and immunology markers in psoriasis vulgaris patients: a randomized controlled trial. Indones Biomed J. 2024, 16:353-62. 10.18585\/inabj.v16i4.3155","journal-title":"Indones Biomed J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-023-02553-1","article-title":"Efficacy of an adjuvant Lactobacillus rhamnosus formula in improving skin lesions as assessed by PASI in patients with plaque psoriasis from a university-affiliated, tertiary-referral hospital in S\u00e3o Paulo (Brazil): a parallel, double-blind, randomized clinical trial","volume":"315","author":"Suriano ES","year":"2023","unstructured":"Suriano ES, Souza MD, Kobata CM, Santos FH, Mimica MJ. Efficacy of an adjuvant Lactobacillus rhamnosus formula in improving skin lesions as assessed by PASI in patients with plaque psoriasis from a university-affiliated, tertiary-referral hospital in S\u00e3o Paulo (Brazil): a parallel, double-blind, randomized clinical trial. Arch Dermatol Res. 2023, 315:1621-9. 10.1007\/s00403-023-02553-1","journal-title":"Arch Dermatol Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s12602-022-09937-1","article-title":"Improvement of psoriasis using oral probiotic Streptococcus salivarius K-12: a case-control 24-month longitudinal study","volume":"14","author":"Zangrilli A","year":"2022","unstructured":"Zangrilli A, Diluvio L, Di Stadio A, Di Girolamo S. Improvement of psoriasis using oral probiotic Streptococcus salivarius K-12: a case-control 24-month longitudinal study. Probiotics Antimicrob Proteins. 2022, 14:573-8. 10.1007\/s12602-022-09937-1","journal-title":"Probiotics Antimicrob Proteins"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s12865-025-00747-y","article-title":"Efficacy and safety of gut microbiota-targeted therapy in patients with psoriasis: a systematic review and meta-analysis of randomized controlled trials","volume":"26","author":"Zhu L","year":"2025","unstructured":"Zhu L, Zhu Y, Xie J, Zhang Y, Wang J, Ji H, Wang X. Efficacy and safety of gut microbiota-targeted therapy in patients with psoriasis: a systematic review and meta-analysis of randomized controlled trials. BMC Immunol. 2025, 26:72. 10.1186\/s12865-025-00747-y","journal-title":"BMC Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3305","article-title":"Efficacy and safety of oral administration of a mixture of probiotic strains in patients with psoriasis: a randomized controlled clinical trial","volume":"99","author":"Navarro-L\u00f3pez V","year":"2019","unstructured":"Navarro-L\u00f3pez V, Mart\u00ednez-Andr\u00e9s A, Ram\u00edrez-Bosc\u00e1 A, et al.. Efficacy and safety of oral administration of a mixture of probiotic strains in patients with psoriasis: a randomized controlled clinical trial. Acta Derm Venereol. 2019, 99:1078-84. 10.2340\/00015555-3305","journal-title":"Acta Derm Venereol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3529","article-title":"Erratum: efficacy and safety of oral administration of a mixture of probiotic strains in patients with psoriasis: a randomized controlled clinical trial","volume":"100","author":"Navarro-L\u00f3pez V","year":"2020","unstructured":"Navarro-L\u00f3pez V, Mart\u00ednez-Andr\u00e9s A, Ram\u00edrez-Bosc\u00e1 A, et al.. Erratum: efficacy and safety of oral administration of a mixture of probiotic strains in patients with psoriasis: a randomized controlled clinical trial. Acta Derm Venereol. 2020, 100:adv00168. 10.2340\/00015555-3529","journal-title":"Acta Derm Venereol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4549134","article-title":"The efficacy of Lactocare\u00ae synbiotic on the clinical symptoms in patients with psoriasis: a randomized, double-blind, placebo-controlled clinical trial","volume":"2022","author":"Akbarzadeh A","year":"2022","unstructured":"Akbarzadeh A, Alirezaei P, Doosti-Irani A, Mehrpooya M, Nouri F. The efficacy of Lactocare\u00ae synbiotic on the clinical symptoms in patients with psoriasis: a randomized, double-blind, placebo-controlled clinical trial. Dermatol Res Pract. 2022, 2022:4549134. 10.1155\/2022\/4549134","journal-title":"Dermatol Res Pract"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241311225","article-title":"Transforming psoriasis care: probiotics and prebiotics as novel therapeutic approaches","volume":"24","author":"Buha\u0219 MC","year":"2023","unstructured":"Buha\u0219 MC, Candrea R, Gavrila\u0219 LI, Miere D, T\u0103taru A, Boca A, C\u0103tinean A. Transforming psoriasis care: probiotics and prebiotics as novel therapeutic approaches. Int J Mol Sci. 2023, 24:11225. 10.3390\/ijms241311225","journal-title":"Int J Mol Sci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnesp.2021.09.004","article-title":"Probiotic supplementation improves clinical outcomes and quality of life indicators in patients with plaque psoriasis: a randomized double-blind clinical trial","volume":"46","author":"Moludi J","year":"2021","unstructured":"Moludi J, Khedmatgozar H, Saiedi S, Razmi H, Alizadeh M, Ebrahimi B. Probiotic supplementation improves clinical outcomes and quality of life indicators in patients with plaque psoriasis: a randomized double-blind clinical trial. Clin Nutr ESPEN. 2021, 46:33-9. 10.1016\/j.clnesp.2021.09.004","journal-title":"Clin Nutr ESPEN"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1177\/24755303221142296","article-title":"The role of probiotics as an adjunctive therapy in psoriasis","volume":"8","author":"Gilli IO","year":"2023","unstructured":"Gilli IO, da Silva GC, Mendes V, Duarte MG, Tanaka AA. The role of probiotics as an adjunctive therapy in psoriasis. J Psoriasis Psoriatic Arthritis. 2023, 8:49-55. 10.1177\/24755303221142296","journal-title":"J Psoriasis Psoriatic Arthritis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1356","article-title":"Interactions between toll-like receptors signaling pathway and gut microbiota in host homeostasis","volume":"12","author":"Chen L","year":"2024","unstructured":"Chen L, Zhang L, Hua H, Liu L, Mao Y, Wang R. Interactions between toll-like receptors signaling pathway and gut microbiota in host homeostasis. Immun Inflamm Dis. 2024, 12:e1356. 10.1002\/iid3.1356","journal-title":"Immun Inflamm Dis"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01655-6","article-title":"Signaling pathways and targeted therapies for psoriasis","volume":"8","author":"Guo J","year":"2023","unstructured":"Guo J, Zhang H, Lin W, Lu L, Su J, Chen X. Signaling pathways and targeted therapies for psoriasis. Signal Transduct Target Ther. 2023, 8:437. 10.1038\/s41392-023-01655-6","journal-title":"Signal Transduct Target Ther"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.967","article-title":"Curcumin alleviates imiquimod-induced psoriasis-like inflammation and regulates gut microbiota of mice","volume":"11","author":"Cai Z","year":"2023","unstructured":"Cai Z, Wang W, Zhang Y, Zeng Y. Curcumin alleviates imiquimod-induced psoriasis-like inflammation and regulates gut microbiota of mice. Immun Inflamm Dis. 2023, 11:e967. 10.1002\/iid3.967","journal-title":"Immun Inflamm Dis"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.70080","article-title":"Obesity and chronic inflammation: implications for rheumatoid arthritis, spondyloarthritis, and ulcerative colitis","volume":"13","author":"Corrado A","year":"2025","unstructured":"Corrado A, Guadagni I, Picarelli G, Variola A. Obesity and chronic inflammation: implications for rheumatoid arthritis, spondyloarthritis, and ulcerative colitis. Immun Inflamm Dis. 2025, 13:e70080. 10.1002\/iid3.70080","journal-title":"Immun Inflamm Dis"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.36849\/JDD.6237","article-title":"Probiotics supplementation improves quality of life, clinical symptoms, and inflammatory status in patients with psoriasis","volume":"21","author":"Moludi J","year":"2022","unstructured":"Moludi J, Fathollahi P, Khedmatgozar H, Pourteymour Fard Tabrizi F, Ghareaghaj Zare A, Razmi H, Amirpour M. Probiotics supplementation improves quality of life, clinical symptoms, and inflammatory status in patients with psoriasis. J Drugs Dermatol. 2022, 21:637-44. 10.36849\/JDD.6237","journal-title":"J Drugs Dermatol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.25682","article-title":"Microbiota links to neural dynamics supporting threat processing","volume":"43","author":"Hall CV","year":"2022","unstructured":"Hall CV, Harrison BJ, Iyer KK, et al.. Microbiota links to neural dynamics supporting threat processing. Hum Brain Mapp. 2022, 43:733-49. 10.1002\/hbm.25682","journal-title":"Hum Brain Mapp"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/435546-efficacy-of-probiotic-supplementation-in-the-management-of-psoriasis-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T22:00:05Z","timestamp":1764626405000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/435546-efficacy-of-probiotic-supplementation-in-the-management-of-psoriasis-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.98265","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,1]]}}}